SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-01-500010
Filing Date
2001-05-07
Accepted
2001-05-07 00:00:00
Documents
6
Period of Report
2001-03-31

Document Format Files

Seq Description Document Type Size
1 EXHIBIT 10.233 ligandex10-233.txt EX-10 9836
2 EXHIBIT 10.234 ligandex10-234.txt EX-10 4934
3 EXHIBIT 10.235 ligandex10-235.txt EX-10 119069
4 EXHIBIT 10.236 ligandex10-236.txt EX-10 2738
5 EXHIBIT 10.237 ligandex10-237.txt EX-10 52310
6 LIGAND MARCH 31, 2001 10Q ligand030110q.htm 10-Q 100403
  Complete submission text file 0000886163-01-500010.txt   291350
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 1624508
SIC: 2834 Pharmaceutical Preparations